The Egyptian Drug Authority (EDA) has issued its annual report on the outcomes of pharmacovigilance inspection activities, as part of its ongoing efforts to strengthen regulatory oversight within the pharmaceutical sector.

This report represents an important step toward advancing drug-regulatory systems in line with the latest local and international standards. It also serves as a key tool to ensure transparency, and to monitor the safety and effectiveness of medicines available on the local market. Moreover, it enables companies to understand inspection findings, identify the causes of non-compliance with pharmacovigilance requirements, and take the necessary corrective actions to ensure the provision of safe and effective medicines for citizens.

The report includes detailed analytical data covering the number of companies inspected, in addition to precise statistics on the observations recorded during the inspection activities.

These results also reflect the commitment of companies and relevant entities to approved standards, thereby strengthening confidence in the pharmaceutical sector at both the local and international levels.

It is worth noting that the World Health Organization’s accreditation of the Egyptian Drug Authority represents a significant milestone that demonstrates the Authority’s adherence to the highest standards of quality and safety in managing the continuous monitoring and assessment of medicine safety, and further reinforces the credibility of the Egyptian pharmaceutical regulatory system globally.

To access the report, please click the following link:
https://shorturl.at/iSGIl